Affiliation:
1. The S. Fyodorov Eye Microsurgery Federal State Institution
Abstract
The Purpose— to develop the technology and to evaluate the clinical results of personalized laser treatment of patients with chronic central serous chorioretinopathy (CSC) in a micropulse mode with individual selection of energy parameters on the navigation system Navilas 577s.Patients and Methods. 19 patients (22 eyes) with CSC after micropulse laser treatment were analyzed. The initial best corrected visual acuity (BCVA) was 0.4 to 1.0. According to OCT, the height of the detachment of the neurosensory retina varied from 83 to 259 microns. Retinal sensitivity of the central zone was from 20.2 to 29.7 dB. Before laser treatment were individually selected the optimal energy parameters for each patient. The treatment was performed on a Navilas 577s laser system. The follow-up were 1 and 3 months.Results. 1 month after treatment the positive dynamics of functional and anatomical results in all patients was observed. Mean BCVA increased in the group to 0.81 ± 0.04. The central retinal sensitivity raised on average in the group up to 25.7 ± 0.6 dB. After 3 months, mean BCVA was 0.96 ± 0.02. Mean central retinal sensitivity increased to 26.4 ± 0.57 dB. The study revealed a high correlation between visual acuity and the central retinal thickness (0.72) and medium correlation between foveal retinal sensitivity and central retinal thickness in fovea (0.60), respectively. The correlation among visual acuity, retinal sensitivity and the symptom’s duration of the disease is negative medium (-0.63) and significant (-0.72), respectively.Conclusions. The developed personalized technology of laser treatment of chronic central serous chorioretinopathy with a micropulse mode with an individual selection of energy parameters on the Navilas 577s navigation system showed high clinical efficiency and safety. It has been established that in the course of the longstanding duration of the disease irreversible changes in the chorioretinal complex structure occured, thinning of the foveal photoreceptors layer leading to a decrease in the central retinal sensitivity and visual acuity, which substantiate the necessity for early and maximally functional-saving treatment.
Publisher
PE Polunina Elizareta Gennadievna
Reference26 articles.
1. Shchegoleva I.V., Budzinskaya M.V. Etiologiya i patogenez tsentral'noi seroznoi khorioretinopatii. Vestnik oftal'mologii. 2010:3;55–58 [Shegoleva I.V., Budzinskaya M.V. Etiology and pathogenesis of central serous chorioretinopathy. Annals of Ophthalmology = Vestnik oftal’mologii. 2010:3;55–58 (In Russ.)].
2. Elsner H., Pörksen E., Klatt C., Bunse A., Theisen-Kunde D., Brinkmann R., Birngruber R., Laqua H., Roider J. Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1638–1645. DOI: 10.1007/s00417-006-0368-5
3. Framme C., Walter A., Berger L., Prahs P., Alt C., Theisen-Kunde D., Kowal J., Brinkmann R. Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy. Ophthalmologica. 2015;234(4):177–188. DOI: 10.1159/000439188
4. Piccolino F.C., De La Longrais R.R., Manea M., Cicinelli S. Posterior cystoid retinal degeneration in central serous chorioretinopathy. Retina. 2008 Jul-Aug;28(7):1008–1012. DOI: 10.1097/IAE.0b013e31816b4b86
5. Breukink M.B., Dingemans A.J., den Hollander A.I., Keunen J.E., MacLaren R.E., Fauser S., Querques G., Hoyng C.B., Downes S.M., Boon C.J. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol. 2016. Dec 20;11:39–46. DOI: 10.2147/OPTH.S115685
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献